160 related articles for article (PubMed ID: 26038143)
1. [Research advances on ubiquitin C-terminal hydrolase in oncogenesis and progression].
Yu J; Chen WL
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 44(2):217-22. PubMed ID: 26038143
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin carboxyl-terminal hydrolases: involvement in cancer progression and clinical implications.
Fang Y; Shen X
Cancer Metastasis Rev; 2017 Dec; 36(4):669-682. PubMed ID: 29080080
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) Promotes Hippocampus-Dependent Memory via Its Deubiquitinating Effect on TrkB.
Guo YY; Lu Y; Zheng Y; Chen XR; Dong JL; Yuan RR; Huang SH; Yu H; Wang Y; Chen ZY; Su B
J Neurosci; 2017 Jun; 37(25):5978-5995. PubMed ID: 28500221
[TBL] [Abstract][Full Text] [Related]
4. The potential role of ubiquitin c-terminal hydrolases in oncogenesis.
Fang Y; Fu D; Shen XZ
Biochim Biophys Acta; 2010 Aug; 1806(1):1-6. PubMed ID: 20302916
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.
Radón V; Czesla M; Reichelt J; Fehlert J; Hammel A; Rosendahl A; Knop JH; Wiech T; Wenzel UO; Sachs M; Reinicke AT; Stahl RAK; Meyer-Schwesinger C
Kidney Int; 2018 Jan; 93(1):110-127. PubMed ID: 28754552
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction.
Bishop P; Rocca D; Henley JM
Biochem J; 2016 Aug; 473(16):2453-62. PubMed ID: 27515257
[TBL] [Abstract][Full Text] [Related]
7. Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1.
Meray RK; Lansbury PT
J Biol Chem; 2007 Apr; 282(14):10567-75. PubMed ID: 17259170
[TBL] [Abstract][Full Text] [Related]
8. UCH-L1 Inhibition Suppresses tau Aggresome Formation during Proteasomal Impairment.
Yu Q; Zhang H; Li Y; Liu C; Wang S; Liao X
Mol Neurobiol; 2018 May; 55(5):3812-3821. PubMed ID: 28540657
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells.
Wang WJ; Li QQ; Xu JD; Cao XX; Li HX; Tang F; Chen Q; Yang JM; Xu ZD; Liu XP
Int J Oncol; 2008 Nov; 33(5):1037-45. PubMed ID: 18949367
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin C-terminal hydrolase-L1 protects cystic fibrosis transmembrane conductance regulator from early stages of proteasomal degradation.
Henderson MJ; Vij N; Zeitlin PL
J Biol Chem; 2010 Apr; 285(15):11314-25. PubMed ID: 20147297
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin C-terminal hydrolase-L1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4.
Kim HJ; Magesh V; Lee JJ; Kim S; Knaus UG; Lee KJ
Oncotarget; 2015 Jun; 6(18):16287-303. PubMed ID: 25915537
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin C-terminal hydrolase-L1 plays a key role in angiogenesis by regulating hydrogen peroxide generated by NADPH oxidase 4.
Song IK; Kim HJ; Magesh V; Lee KJ
Biochem Biophys Res Commun; 2018 Jan; 495(1):1567-1572. PubMed ID: 29128359
[TBL] [Abstract][Full Text] [Related]
13. Length of the active-site crossover loop defines the substrate specificity of ubiquitin C-terminal hydrolases for ubiquitin chains.
Zhou ZR; Zhang YH; Liu S; Song AX; Hu HY
Biochem J; 2012 Jan; 441(1):143-9. PubMed ID: 21851340
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin Carboxyl-Terminal Hydrolases (UCHs): Potential Mediators for Cancer and Neurodegeneration.
Sharma A; Liu H; Tobar-Tosse F; Chand Dakal T; Ludwig M; Holz FG; Loeffler KU; Wüllner U; Herwig-Carl MC
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486284
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin C-terminal hydrolase-L1 expression in non-small-cell lung cancer and its association with clinicopathological features and prognosis.
Yu J; Yu S; Jia M; Sun PL; Gao H
Virchows Arch; 2022 Mar; 480(3):577-585. PubMed ID: 34757486
[TBL] [Abstract][Full Text] [Related]
16. Friend or Foe: UCHL3 Mediated Carcinogenesis and Current Approaches in Small Molecule Inhibitors' Development.
Samy MA; Abd El Fatah NM; Yahia SE; Arafa RK
Curr Med Chem; 2021; 28(42):8782-8799. PubMed ID: 34238144
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy.
Meyer-Schwesinger C; Meyer TN; Sievert H; Hoxha E; Sachs M; Klupp EM; Münster S; Balabanov S; Carrier L; Helmchen U; Thaiss F; Stahl RA
Am J Pathol; 2011 May; 178(5):2044-57. PubMed ID: 21514420
[TBL] [Abstract][Full Text] [Related]
18. The ubiquitin C-terminal hydrolase L1 (UCH-L1) C terminus plays a key role in protein stability, but its farnesylation is not required for membrane association in primary neurons.
Bishop P; Rubin P; Thomson AR; Rocca D; Henley JM
J Biol Chem; 2014 Dec; 289(52):36140-9. PubMed ID: 25326379
[TBL] [Abstract][Full Text] [Related]
19. β-Amyloid (Aβ) oligomers impair brain-derived neurotrophic factor retrograde trafficking by down-regulating ubiquitin C-terminal hydrolase, UCH-L1.
Poon WW; Carlos AJ; Aguilar BL; Berchtold NC; Kawano CK; Zograbyan V; Yaopruke T; Shelanski M; Cotman CW
J Biol Chem; 2013 Jun; 288(23):16937-16948. PubMed ID: 23599427
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis.
Kim HJ; Kim YM; Lim S; Nam YK; Jeong J; Kim HJ; Lee KJ
Oncogene; 2009 Jan; 28(1):117-27. PubMed ID: 18820707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
